The 30% is very misleading.
None of the other companies had a CRL for landscape vs portrait and wash hands after use.... The threat of a new reason for CRL is almost non existent.
That being said, the SP can do whatever it likes up to and post approval.
Im waiting for the big pharma buyout .... or BOT to hit 5% market. Let's see how long that takes. Will they pay dividends ?
current share price represents 3000 sufferers at pe 36:1, with 50% margin on 700 usd a unit.
That is 0.08 of 1% of the market.
Times by 10, and we are still not at 1% or Kakens sales year 2 after entering Japanese market with same product
The 30% is very misleading.None of the other companies had a CRL...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.015(5.17%) |
Mkt cap ! $433.1M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.0¢ | 27.5¢ | $1.164M | 4.100M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 534239 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 77302 | 2 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.0¢ |
Change
-0.015 ( 2.61 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 29.0¢ | 27.5¢ | 2348390 | ||
| Last updated 15.59pm 28/05/2024 ? | |||||
| BOT (ASX) Chart |